Tips from Other Journals
Safety of Intranasal Steroids in Young Children
FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.
FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.
Am Fam Physician. 2004 Feb 1;69(3):687-688.
Intranasal corticosteroids are well tolerated in older children and adults. These medications do not suppress the hypothalamic-pituitary-adrenal axis function, but it is not known whether they have adverse effects in children younger than four years. In this study, Galant and colleagues evaluated the potential systemic effects of intranasal fluticasone propionate in children two to three years of age.
This randomized, double-blinded, placebo-controlled study recruited children with allergy symptoms. For six weeks, one group received daily fluticasone propionate in a dosage of 200 mcg, and one group received placebo intranasal spray. Baseline and end-of-study 12-hour creatinine-corrected urinary free cortisol levels were compared.
Sixty of 65 enrolled patients completed the study. The mean change from baselines in 12-hour creatinine-corrected urinary free cortisol concentration was equivalent in both groups. The adjusted mean change from baseline value in the fluticasone group was 0.98, and the change was 0.94 in the placebo group. A similar proportion of both groups reported at least one adverse event, with the incidence of specific adverse events being comparable between the two groups. In the opinion of the investigators, the slightly higher occurrence of vomiting and gastric pain in the fluticasone group was unrelated to the medication. One child in the fluticasone group was withdrawn from the study because of epistaxis and nose pain.
Results of this study showed that intranasal corticosteroids had no differential effects on the hypothalamic-pituitary-adrenal axis function in children two to three years of age compared with placebo. There were few adverse events in either group. The findings correspond to similar results in studies performed on older children and adults.
Galant SP, et al. Lack of effect of fluticasone propionate aqueous nasal spray on the hypothalamic-pituitary-adrenal axis in 2- and 3-year-old patients. Pediatrics. July 2003;112:96–100.
Copyright © 2004 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact email@example.com for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions